To the full analysis
Buyback calculator for City Therapeutics
City Therapeutics Stock: Dividend
CTYCity Therapeutics does not currently pay a dividend. From fiscal 2017 to 2019, City Therapeutics bought back its own shares for $8M.
Whether City Therapeutics Inc. pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.
Daily figure as of 20 Nov 2026
Free Cash Flow and Buybacks
| Fiscal year | Free cash flow | Share buybacks | Shares outstanding |
|---|---|---|---|
| 2019 | $2.28B | $2M | 0 |
| 2018 | $2.75B | $5M | 0 |
| 2017 | $1.11B | $1M | 0 |
| 2016 | $1.39B | $5M | 0 |
| 2015 | $1.34B | $3M | 0 |
Data and Required Disclosures
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026
- Price: closing price of 19 Nov 2026
- Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2019. MEQIRI calculates the score and fair value itself every night.
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
